The onset of multiple sclerosis (MS) in older individuals correlates with a higher risk of developing primary progressive MS, faster progression to secondary progressive MS, and increased disability ...
Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) had its price objective increased by equities research analysts at The Goldman Sachs Group from $5.50 to $7.50 in a note issued to investors on ...
Treatment with xalnesiran, a small interfering RNA molecule, plus an immunomodulator resulted in hepatitis B surface antigen loss among adults with chronic HBV infection, according to a study ...